This proposal requests continued support for the Medical Scientist Training Program (MSTP) at Vanderbilt University School of Medicine. The primary goal of the Vanderbilt MSTP is to identify, mentor, and foster the careers of future leaders in academic medicine who are dedicated to improving human health through discovery. The program is based on rigorous training in clinical medicine and scientific inquiry. Successful completion of the MSTP leads to both M.D. and Ph.D. degrees. Core elements of the program developed specifically for dual-degree students include a foundational course in research, literature-based seminar series, clinical preceptorship program, data club, leadership workshop, career development workshop, physician-scientist speaker series, and an annual retreat. Formal instruction in the responsible conduct of research is provided throughout the curriculum. MSTP students are assigned to one of four innovative advising colleges that provide a framework for academic counseling by faculty and peers. Current students play key roles in new student recruitment, program administration, and curriculum development. Seventy-two percent of our graduates with established careers hold academic or private-sector research positions, including two deans, four department chairs, and 24 full professors. More recent graduates have been placed in superb residencies and fellowships. The 92 current trainees come from 57 colleges and universities distributed across North America. The nationwide applicant pool results from concerted recruiting efforts, including those focused on the recruitment of students from groups underrepresented in medicine. In the current year, 380 applications have been received, from which 12 students will be selected to enter the incoming class. The proposed goal is to increase the size of the program to a steady state of 112 students over the next five years. Extramural research funding at Vanderbilt has increased from $389 million to $444 million since 2008. Research opportunities for MSTP trainees include established strengths in biomedical informatics, cancer biology, cell biology, clinical pharmacology, diabetes, neurosciences, toxicology, and vaccine science as well as new areas of emphasis in chemical and physical biology, drug discovery, genetics, imaging sciences, microbial pathogenesis, pharmacogenomics, and structural biology. As such, the educational environment for physician- scientists at Vanderbilt is outstanding. The proposal requests an increase in funded positions to 24 for the five- year project period. Ongoing support for the Vanderbilt MSTP is justified based on the strength of the applicant pool, numerous opportunities for physician-scientist training, an institutional commitment to the education of leaders in biomedical research, and success of our graduates in academic medicine.

Public Health Relevance

The Vanderbilt Medical Scientist Training Program supports the training of physician-scientists who seek to improve human health through basic, translational, or clinical research. The broad public health significance of this program will be realized through the academic and scholarly accomplishments of the trainees, with connections to both the direct treatment of patients in the clinical setting and the discovery of basic disease mechanisms and new therapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007347-40
Application #
9518920
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Gindhart, Joseph G
Project Start
1977-07-01
Project End
2019-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
40
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
965717143
City
Nashville
State
TN
Country
United States
Zip Code
37240
Stier, Matthew T; Zhang, Jian; Goleniewska, Kasia et al. (2018) IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow. J Exp Med 215:263-281
Rogers, Meredith C; Lamens, Kristina D; Shafagati, Nazly et al. (2018) CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses. J Immunol 201:1253-1266
Jefferson, Angela L; Cambronero, Francis E; Liu, Dandan et al. (2018) Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults. Circulation 138:1951-1962
Ji, Xiangming; Niu, Xinnan; Qian, Jun et al. (2018) A Phenome-Wide Association Study Uncovers a Role for Autoimmunity in the Development of Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 58:777-779
Cheng, Frances Y; Fleming, Jonathan T; Chiang, Chin (2018) Bergmann glial Sonic hedgehog signaling activity is required for proper cerebellar cortical expansion and architecture. Dev Biol 440:152-166
Bloodworth, Melissa H; Rusznak, Mark; Bastarache, Lisa et al. (2018) Association of ST2 polymorphisms with atopy, asthma, and leukemia. J Allergy Clin Immunol 142:991-993.e3
Fensterheim, Benjamin A; Young, Jamey D; Luan, Liming et al. (2018) The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism. J Immunol 200:3777-3789
Thompson, Joshua J; Williams, Christopher S (2018) Protein Phosphatase 2A in the Regulation of Wnt Signaling, Stem Cells, and Cancer. Genes (Basel) 9:
Sugiura, Ayaka; Rathmell, Jeffrey C (2018) Metabolic Barriers to T Cell Function in Tumors. J Immunol 200:400-407
Jarrett, Angela M; Lima, Ernesto A B F; Hormuth 2nd, David A et al. (2018) Mathematical models of tumor cell proliferation: A review of the literature. Expert Rev Anticancer Ther 18:1271-1286

Showing the most recent 10 out of 536 publications